FDA 503B outsourcing facilities in North Carolina
North Carolina has 1 FDA-registered 503B outsourcing facility in the PeptideGrids directory, none with FDA drug recalls on record, the earliest registered in 2024. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| Apothecary Pharma, LLC | Cary | 2024 | None on record |
503B compounding in North Carolina
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in North Carolina must hold the appropriate state pharmacy license. Verify any facility's current license with the North Carolina Board of Pharmacy.
Compounded peptides and GLP-1s
503B facilities are a primary supply route for compounded peptides and GLP-1s, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the full GLP-1 and therapeutic peptide databases, or the national directory.
Frequently asked questions
How many FDA 503B outsourcing facilities are in North Carolina?
1 FDA-registered 503B outsourcing facility is listed in North Carolina on PeptideGrids, the earliest registered in 2024.
Which North Carolina 503B facilities have FDA recalls on record?
None of the North Carolina facilities in our directory have FDA drug recalls on record.
How do I verify a pharmacy license in North Carolina?
Use the North Carolina Board of Pharmacy license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.